<DOC>
	<DOCNO>NCT02807181</DOCNO>
	<brief_summary>The study evaluate benefit apply Selective Internal Radiation Therapy ( SIRT ) use SIR-Spheres Y-90 resin microspheres prior receive systemic chemotherapy treatment ( cisplatin-gemcitabine , CIS-GEM ) patient unresectable intrahepatic cholangiocarcinoma . Half patient randomize CIS-GEM chemotherapy plus SIRT , half patient randomized CIS-GEM alone .</brief_summary>
	<brief_title>SIRT Followed CIS-GEM Chemotherapy Versus CIS-GEM Chemotherapy Alone 1st Line Treatment Patients With Unresectable Intrahepatic Cholangiocarcinoma</brief_title>
	<detailed_description>This clinical study prospective , multicenter , randomize , control study evaluate SIR-Spheres Y-90 resin microspheres follow cisplatin-gemcitabine ( CIS-GEM ) chemotherapy vs. CIS-GEM chemotherapy alone first-line treatment patient unresectable intrahepatic cholangiocarcinoma . Randomized patient follow death , withdrawal consent , end study .</detailed_description>
	<mesh_term>Cholangiocarcinoma</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>Willing , able mentally competent provide write informed consent . Aged 18 year old . Histologically cytologically confirm unresectable nonablatable intrahepatic cholangiocarcinoma . Liveronly liver predominant intrahepatic cholangiocarcinoma . Patient permit locoregional lymph node involvement define : portal LN &lt; /= 2 cm and/or para aortic LN &lt; /= 1.5 cm long diameter , and/or 2 indeterminate lung lesion &lt; 1 cm lung lesion positron emission tomography ( PET ) negative . Chemotherapy na√Øve . Adjuvant chemotherapy permit . Eastern Cooperative Oncology Group ( ECOG ) performance status 0 1 . Adequate hematological function define : Hemoglobin &gt; /= 10g/dL White Blood Cell count ( WBC ) &gt; /= 3.0 x 10^9/L Absolute neutrophil count ( ANC ) &gt; /= 1.5 x 10^9/L Platelet count &gt; /= 100,000/mm^3 Adequate liver function define : Total bilirubin &lt; /= 30 umol/L ( 1.75 mg/dL ) Albumin &gt; /= 30 g/L Adequate renal function define : Serum urea serum creatinine &lt; 1.5 time upper limit normal ( ULN ) Creatinine clearance &gt; /= 45 ml/min ( calculate CockcroftGault Equation ) Life expectancy least 3 month without active treatment Female patient must either postmenopausal , sterile ( surgically radiation chemicallyinduced ) , sexually active use acceptable method contraception study . Male patient must surgically sterile sexually active must use acceptable method contraception study . Considered suitable receive either regimen clinical judgement treat investigator . Patients nonmeasurable lesion liver accord RECIST criterion Incomplete recovery previous liver surgery , e.g . unresolved biliary tree obstruction biliary sepsis inadequate liver function Biliary stent situ Main trunk Portal Vein Thrombosis ( PVT ) Ascites , even control diuretic . ( A minor perihepatic rim ascites detect image acceptable ) . Mixed hepatocellular carcinoma intrahepatic cholangiocarcinoma ( HCCICC ) disease History prior malignancy . Exceptions include insitu carcinoma cervix treat conebiopsy/resection , nonmetastatic basal and/or squamous cell carcinoma skin , recurrent intrahepatic cholangiocarcinoma post local treatment early stage ( stage 1 ) malignancy adequately resect curative intent least 5 year prior study entry Suspicion bone metastasis/metastases central nervous system metastasis/metastases clinical image examination . Prior internal external radiation deliver liver . Pregnancy ; breast feeding . Participation within 28 day prior randomization , active part another clinical study would compromise endpoint study . Evidence ongoing active infection may affect treatment feasibility outcome . Prior Whipple 's procedure .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>